发明名称 |
PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF |
摘要 |
The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus. |
申请公布号 |
US2014315832(A1) |
申请公布日期 |
2014.10.23 |
申请号 |
US201414253935 |
申请日期 |
2014.04.16 |
申请人 |
BROEDL Uli Christian;JOHANSEN Odd-Erik;MAYOUX Eric Williams;SOLEYMANLOU Nima;von EYNATTEN Maximilian;WOERLE Hans-Juergen;CHERNEY David Z.I.;PERKINS Bruce A. |
发明人 |
BROEDL Uli Christian;JOHANSEN Odd-Erik;MAYOUX Eric Williams;SOLEYMANLOU Nima;von EYNATTEN Maximilian;WOERLE Hans-Juergen;CHERNEY David Z.I.;PERKINS Bruce A. |
分类号 |
A61K31/7048;A61K45/06 |
主分类号 |
A61K31/7048 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating, preventing, protecting against, reducing the risk of, delaying the occurrence of and/or delaying the progression of chronic kidney disease in a patient, said method comprising administering empagliflozin, optionally in combination with one or more other therapeutic substances, to the patient. |
地址 |
Mainz am Rhein DE |